BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25574005)

  • 1. RNA. Prescribing splicing.
    Guigó R; Valcárcel J
    Science; 2015 Jan; 347(6218):124-5. PubMed ID: 25574005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation and alternative splicing.
    Estivill X
    Nat Biotechnol; 2015 Apr; 33(4):357-9. PubMed ID: 25850059
    [No Abstract]   [Full Text] [Related]  

  • 3. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
    Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
    Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-Wide Annotation of circRNAs and Their Alternative Back-Splicing/Splicing with CIRCexplorer Pipeline.
    Dong R; Ma XK; Chen LL; Yang L
    Methods Mol Biol; 2019; 1870():137-149. PubMed ID: 30539552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting splicing in spinal muscular atrophy.
    Burnett BG; Sumner CJ
    Ann Neurol; 2008 Jan; 63(1):3-6. PubMed ID: 18232015
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aberrant mRNA splicing in human diseases].
    Imaizumi K
    Tanpakushitsu Kakusan Koso; 2006 Nov; 51(14 Suppl):2287-93. PubMed ID: 17471954
    [No Abstract]   [Full Text] [Related]  

  • 7. Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence.
    Marquis J; Meyer K; Angehrn L; Kämpfer SS; Rothen-Rutishauser B; Schümperli D
    Mol Ther; 2007 Aug; 15(8):1479-86. PubMed ID: 17505471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleic Acid-Targeted Small Molecules have Therapeutic Potential in the Treatment of Spinal Muscular Atrophy: Small-molecule drugs that can selectively bind RNA and modulate pre-mRNA splicing have potential as a treatment strategy for human disease, including spinal muscular atrophy.
    Am J Med Genet A; 2018 Aug; 176(8):1698-1699. PubMed ID: 30136439
    [No Abstract]   [Full Text] [Related]  

  • 9. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
    Kashima T; Manley JL
    Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer.
    Sun MH; Cai Q; Fu G; Ren S; Mo S; Xu Y; Ding C; Zhang T; Zhu X; Xu X; Min D; Cai S; Luo D; Shi Y; Shi D
    Hum Genet; 2004 Mar; 114(4):411. PubMed ID: 15046112
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene symbol: hMLH1. Disease: Hereditary nonpolyposis colorectal cancer.
    Sun MH; Cai Q; Fu G; Ren S; Mo S; Xu Y; Ding C; Zhang T; Zhu X; Xu X; Min D; Cai S; Luo D; Shi Y; Shi D
    Hum Genet; 2004 Mar; 114(4):411. PubMed ID: 15046110
    [No Abstract]   [Full Text] [Related]  

  • 12. Antisense methods to modulate pre-mRNA splicing.
    Seo J; Ottesen EW; Singh RN
    Methods Mol Biol; 2014; 1126():271-83. PubMed ID: 24549671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a splicing enhancer in MLH1 using COMPARE, a new assay for determination of relative RNA splicing efficiencies.
    Xu DQ; Mattox W
    Hum Mol Genet; 2006 Jan; 15(2):329-36. PubMed ID: 16357104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a one-base germline deletion (codon 888 del C) and an intron splice acceptor site polymorphism in hMSH2.
    Swensen J; Lewis CM; Cannon-Albright LA
    Hum Mutat; 1997; 10(1):80-1. PubMed ID: 9222765
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole-transcriptome sequencing in blood provides a diagnosis of spinal muscular atrophy with progressive myoclonic epilepsy.
    Kernohan KD; Frésard L; Zappala Z; Hartley T; Smith KS; Wagner J; Xu H; McBride A; Bourque PR; Consortium CRC; Bennett SAL; Dyment DA; Boycott KM; Montgomery SB; Warman Chardon J
    Hum Mutat; 2017 Jun; 38(6):611-614. PubMed ID: 28251733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HnRNP C1/C2 may regulate exon 7 splicing in the spinal muscular atrophy gene SMN1.
    Irimura S; Kitamura K; Kato N; Saiki K; Takeuchi A; Gunadi ; Matsuo M; Nishio H; Lee MJ
    Kobe J Med Sci; 2009 Mar; 54(5):E227-36. PubMed ID: 19628962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding spinal muscular atrophy.
    Nat Struct Biol; 2001 Jan; 8(1):1. PubMed ID: 11135654
    [No Abstract]   [Full Text] [Related]  

  • 19. A leaky splicing mutation affecting SMN1 exon 7 inclusion explains an unexpected mild case of spinal muscular atrophy.
    Vezain M; Gérard B; Drunat S; Funalot B; Fehrenbach S; N'Guyen-Viet V; Vallat JM; Frébourg T; Tosi M; Martins A; Saugier-Veber P
    Hum Mutat; 2011 Sep; 32(9):989-94. PubMed ID: 21542063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of an exon splicing enhancer in exon 3 of MLH1 is the cause of HNPCC in a Quebec family.
    McVety S; Li L; Gordon PH; Chong G; Foulkes WD
    J Med Genet; 2006 Feb; 43(2):153-6. PubMed ID: 15923275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.